HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study.

Abstract
Adenomyosis is a common disorder in premenopausal women that causes dysmenorrhea, pelvic pain and menorrhagia. Considering that adenomyosis is an estrogen-dependent disease, the medical treatment is based on this hormone. Effective and well-tolerated medical treatments for symptomatic adenomyosis are needed. Dienogest, an oral progestin, has been extensively investigated in the treatment of endometriosis. In this report, we present the results on the efficacy and safety of dienogest in the treatment of symptomatic adenomyosis. Seventeen patients with symptomatic adenomyosis were included in this study, of which 15 continued dienogest for up to 24 weeks. Dienogest significantly reduced adenomyosis-associated pelvic pain as well as serum CA-125 and CA19-9 levels. It also demonstrated a modest suppression of estradiol (>50 pg/ mL), which is consistent with the findings of other reports. During treatment, five patients experienced worsening anemia because of metrorrhagia, which is the most frequent adverse effect associated with dienogest. This report suggests that dienogest is an effective and well-tolerated therapy for symptomatic adenomyosis.
AuthorsTetsuya Hirata, Gentaro Izumi, Masashi Takamura, Ako Saito, Akari Nakazawa, Miyuki Harada, Yasushi Hirota, Kaori Koga, Tomoyuki Fujii, Yutaka Osuga
JournalGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (Gynecol Endocrinol) Vol. 30 Issue 10 Pg. 726-9 (Oct 2014) ISSN: 1473-0766 [Electronic] England
PMID24905725 (Publication Type: Journal Article)
Chemical References
  • Progesterone Congeners
  • dienogest
  • Nandrolone
Topics
  • Adenomyosis (drug therapy)
  • Adult
  • Female
  • Humans
  • Metrorrhagia (chemically induced)
  • Middle Aged
  • Nandrolone (administration & dosage, adverse effects, analogs & derivatives, pharmacology)
  • Pilot Projects
  • Progesterone Congeners (administration & dosage, adverse effects, pharmacology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: